Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease

Detalles Bibliográficos
Autores principales: Liaudet, Lucas, Szabo, Csaba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278213/
https://www.ncbi.nlm.nih.gov/pubmed/32513242
http://dx.doi.org/10.1186/s13054-020-03055-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278213/
https://www.ncbi.nlm.nih.gov/pubmed/32513242
http://dx.doi.org/10.1186/s13054-020-03055-6

Ejemplares similares